UTMD Utah Medical Products, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · utahmed.com

73.47USD+0.03%Mkt Cap: 233.12M $P/E: 22.391d ago

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$71.30BUSDP/E 26.7

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$22.00BUSDP/E 69.1

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.68BUSDP/E 69.1

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap233.12M USD

Enterprise Value147.73M USD

Revenue (TTM)36.11M USD

Gross Profit22.00M USD

Net Income (TTM)11.29M USD

Revenue/Share11.31 USD

Last Price73.47 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees140

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)22.39

P/E (Forward)—

PEG4.25

EV/EBITDA10.28

EV/Revenue4.09

P/S6.49

P/B1.93

EPS (TTM)3.28

EPS (Forward)—

52W Range

53.6685% of range76.89

52W High76.89 USD

52W Low53.66 USD

Profitability

Gross Margin57.12%

Oper. Margin36.89%

EBITDA Margin39.79%

Profit Margin29.30%

ROE9.46%

ROA9.21%

Growth

Revenue Growth-14.30%

Earnings Growth-10.50%

Cash Flow & Leverage

Operating CF14.69M USD

CapEx (TTM)371.00K USD

FCF Margin24.48%

FCF Yield3.79%

Net Debt-87.33M USD

Net Debt/EBITDA-6.08

Balance Sheet

Debt/Equity0.00

Current Ratio48.62

Quick Ratio44.01

Book Value/Sh38.34 USD

Cash/Share27.49 USD

Dividends

Fwd Div Rate1.24 USD

Trail. Div Rate1.24 USD

Div. Yield1.68%

5Y Avg Yield1.49%

Payout Ratio37.65%

Ex-Div DateSep 17, 2026

Pay DateOct 5, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.3.17M

Float2.78M

Insiders7.18%

Institutions76.55%

Short Interest

Short Ratio4.3d

Short % Float6.64%

Short % Out.5.43%

Shares Short172.18K

Short (prev mo.)139.72K

Technical

SMA 5072.18 (+1.8%)

SMA 20066.65 (+10.2%)

Beta0.39

S&P 52W Chg16.45%

Avg Vol (30d)37.39K

Avg Vol (10d)31.51K

Technical Indicators

RSI (14)51.9

MACD0.6935

MACD Signal0.8617

MACD Hist.-0.1682

BB Upper77.58 USD

BB Middle73.24 USD

BB Lower68.89 USD

BB Width11.87%

ATR (14)1.306 USD

Vol Ratio (20d)1.89x